COVID-19 and cardiovascular disease: what have we learned?

Elena Tessitore; Philippe Meyer

doi:10.4414/smw.2020.20452

Viewpoint

Vol. 150 No. 5153 (2020)

COVID-19 and cardiovascular disease: what have we learned?

Elena Tessitore
Philippe Meyer

DOI: https://doi.org/10.4414/smw.2020.20452
Cite this as:: Swiss Med Wkly. 2020;150:w20452
Published: 31.12.2020

References

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:.https://doi.org/10.1016/S0140-6736(20)30183-5
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. doi:.https://doi.org/10.1001/jama.2020.1585
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi:.https://doi.org/10.1016/S2213-2600(20)30116-8
http://www.intrahug.ch/groupes/coronavirus-de-la-maladie-covid-19/group-news/covid-19-situation.
https://infocovid.smc.unige.ch.
Bramstedt KA. The carnage of substandard research during the COVID-19 pandemic: a call for quality. J Med Ethics. 2020;46(12):803–7. doi:.https://doi.org/10.1136/medethics-2020-106494
https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance.
Kurz D, Eberli FR. Cardiovascular aspects of COVID-19. Swiss Med Wkly. 2020;150:w20417. doi:https://doi.org/10.44414/smw.2020.20417
Phelps M, Christensen DM, Gerds T, Fosbøl E, Torp-Pedersen C, Schou M, et al. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Heart J Qual Care Clin Outcomes. 2020;qcaa081. doi:.https://doi.org/10.1093/ehjqcco/qcaa081
de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A, et al.; MED-ACE2-COVID19 study group. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395(10238):1705–14. doi:.https://doi.org/10.1016/S0140-6736(20)31030-8
Sandoval Y, Januzzi JL, Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(10):1244–58. doi:.https://doi.org/10.1016/j.jacc.2020.06.068

Publication image

How to Cite

1.

Tessitore E, Meyer P. COVID-19 and cardiovascular disease: what have we learned?. Swiss Med Wkly [Internet]. 2020 Dec. 31 [cited 2024 Nov. 18];150(5153):w20452. Available from: https://smw.ch/index.php/smw/article/view/2926

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Henri Lu, Philippe Meyer, Roger Hullin, Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how? A narrative literature review , Swiss Medical Weekly: Vol. 150 No. 3536 (2020)
Matthias Paul, Arnold Eggerschwiler, Gesine Meyer, Christian Studer, Urs Hürlimann, Michael Brändle, Peter Wiesli, Giacomo Gastaldi, Mattia Arrigo, Philippe Meyer, Christian Mueller, Kathrin Zimmermann, Roger Lehmann, Recommendations for early identification of heart failure in patients with diabetes: Consensus statement of the Swiss Society of Endocrinology and Diabetology and the Heart Failure Working Group of the Swiss Society of Cardiology , Swiss Medical Weekly: Vol. 154 No. 10 (2024)
Maciej Albiński, Christian Balmer, Matthias Wilhelm, Philippe Meyer, Matthias Gass, Christian Schmied, Andrea Menafoglio, Susanne Kriemler, Yvan Mivelaz, Dominik Stambach, Mathieu Saubade, Vincent Gremeaux, Boris Gojanovic, Josep Brugada, Aaron Baggish, Vincent Gabus, Paediatric and adolescent athletes in Switzerland: age-adapted proposals for pre-participation cardiovascular evaluation , Swiss Medical Weekly: Vol. 152 No. 0708 (2022)
Nils Perrin, Juan F. Iglesias, Florian Rey, Lamyae Benzakour, Murat Cimci, Stephane Noble, Sophie Degrauwe, Elena Tessitore, François Mach, Marco Roffi, Impact of the COVID-19 pandemic on acute coronary syndromes , Swiss Medical Weekly: Vol. 150 No. 5153 (2020)
Elena Tessitore, Sandra Handgraaf, Antoine Poncet, Maëlle Achard, Stefan Höfer, Sebastian Carballo, Christophe Marti, Cédric Follonier, François Girardin, François Mach, David Carballo, Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode , Swiss Medical Weekly: Vol. 151 No. 4950 (2021)
Roger Hullin, Tamila Abdurashidova, Barbara Pitta-Gros, Sara Schukraft, Valentina Rancati, Henri Lu, Anouck Zurbuchen, Carlo Marcucci, Zied Ltaief, Karl Lefol, Christoph Huber, Manuel Pascual, Piergiorgio Tozzi, Philippe Meyer, Matthias Kirsch, Post-transplant survival with pre-transplant durable continuous-flow mechanical circulatory support in a Swiss cohort of heart transplant recipients , Swiss Medical Weekly: Vol. 153 No. 12 (2023)
Anouck Zurbuchen, Piergiorgio Tozzi, Julien Regamey, Tamila Abdurashidova, Philippe Meyer, Karl Lefol, Manuel Pascual, Patrick Yerly, Vincent Aubert, Stefania Aur, Valentina Rancati, Carlo Marcucci, Marco Rusca, Sam Rotman, Rene Pretre, Matthias Kirsch, Roger Hullin, Has the profile of heart transplantation recipients changed within the last three decades? , Swiss Medical Weekly: Vol. 152 No. 0304 (2022)
Philippe Meyer, Henri Lu, Roger Hullin, Patiromer and medication optimisation in heart failure with reduced ejection fraction: a Swiss perspective , Swiss Medical Weekly: Vol. 150 No. 3940 (2020)

[1] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:.https://doi.org/10.1016/S0140-6736(20)30183-5

[2] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. doi:.https://doi.org/10.1001/jama.2020.1585

[3] Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi:.https://doi.org/10.1016/S2213-2600(20)30116-8

[4] http://www.intrahug.ch/groupes/coronavirus-de-la-maladie-covid-19/group-news/covid-19-situation.

[5] https://infocovid.smc.unige.ch.

[6] Bramstedt KA. The carnage of substandard research during the COVID-19 pandemic: a call for quality. J Med Ethics. 2020;46(12):803–7. doi:.https://doi.org/10.1136/medethics-2020-106494

[7] https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance.

[8] Kurz D, Eberli FR. Cardiovascular aspects of COVID-19. Swiss Med Wkly. 2020;150:w20417. doi:https://doi.org/10.44414/smw.2020.20417

[9] Phelps M, Christensen DM, Gerds T, Fosbøl E, Torp-Pedersen C, Schou M, et al. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Heart J Qual Care Clin Outcomes. 2020;qcaa081. doi:.https://doi.org/10.1093/ehjqcco/qcaa081

[10] de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A, et al.; MED-ACE2-COVID19 study group. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395(10238):1705–14. doi:.https://doi.org/10.1016/S0140-6736(20)31030-8

[11] Sandoval Y, Januzzi JL, Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(10):1244–58. doi:.https://doi.org/10.1016/j.jacc.2020.06.068